Cannabis Battle! 2 Pot Stocks With Very Different Futures

The pot industry is growing at a rapid pace, but choosing winning stocks is getting harder. Learn what makes Green Organic Dutchman (TSX:TGOD) a sell and Cronos Group Inc (TSX:CRON)(NYSE:CRON) a buy.

| More on:

The cannabis market should continue to grow for the next decade and beyond. Many analysts believe the global market could surpass $100 billion in sales by 2030. In order to meet surging demand, pot companies have been ramping their capacity and infrastructure at breakneck speeds. They’ve also been working to secure valuable partnerships to accelerate market adoption.

Even if the pot industry continues to take off, however, it’s no guarantee that every cannabis company will succeed. Consider the solar industry. For 10 years straight, solar demand has continued to mount, yet the industry has seen dozens of bankruptcies.

The early internet was also a good example. In 1999, the internet had the vast majority of its growth days ahead of it, but that year saw hundreds of dot-com businesses disappear.

If you want to succeed investing in the marijuana industry, you’ll need to know which strategies will work and which ones won’t. There are no better examples of this than Green Organic Dutchman (TSX:TGOD) and Cronos Group Inc (TSX:CRON)(NYSE:CRON).

Avoid commoditization

If you invest in the pot market, know one thing: commoditization will ruin the party. At the end of the day, there’s not much differentiation between cannabis production. Compare it to something like wheat, corn, or soy, all of which are grown by commoditized farms fetching a market price.

Regulation is keeping supply limited, but we’ve already seen how cannabis pricing can collapse due to surging numbers of growers. In 2018, Oregon was reportedly “drowning in one million pounds of excess weed,” pushing down prices to historically low levels.

If you want to avoid commoditization, avoid companies like Green Organic, as Green Organic is positioned as a pure grower, with no differentiation apart from its organic focus.

While organic cannabis has fetched a higher price, it’s just as susceptible to steep pricing declines. Green Organic’s lack of differentiation was demonstrated when its former partner, Aurora Cannabis Inc, opted to terminate its agreement to buy 20% of its produce, choosing instead to source the cannabis elsewhere.

Wherever pot pricing goes, so too will Green Organic. That’s a risky bet as commoditization looms. Instead, choose companies that can better dictate their own future.

Brands and influence

Soda is a commodity, but you wouldn’t be able to tell looking at Coca-Cola Co. As a $250 billion behemoth, Coca-Cola has demonstrated that it can sustain high margins for decades at a time. Another example is cigarettes.

Tobacco is largely commoditized, yet firms like Altria Group Inc (formerly Philip Morris) continue to rake in billions every year. Learning from firms like Altria is critical for any pot company looking to capitalize long term. Fortunately, one cannabis firm has direct access.

Last year, Altria and Cronos agreed to a $1.8 billion partnership that should align each companies interest for the next decade and beyond. Altria is the most experienced partner conceivable when it comes to navigating a highly regulated, increasingly commoditized industry.

If any cannabis company succeeds, it should be Cronos. If Green Organic’s stock will follow cannabis pricing, Cronos’ stock should follow industry-wide growth. That’s a much better bet.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »